This compound is a chiral pharmaceutical intermediate featuring both an epoxide ring and a nitrobenzenesulfonate ester group. Its primary significance lies in its use as a synthetic building block for the preparation of enantiomerically pure pharmaceutical compounds.
نطاق المحتوى: تتعلق المعلومات الواردة في هذه الصفحة بتحديد المواد الكيميائية وبسياقات التوريد الصناعي والبحث والإنتاج. وهي لا تشكّل ادعاءً علاجياً أو نصيحة طبية أو إرشادات لاستخدام الأدوية.
هل تشتري أو تورد هذا المركب؟
أضف مخزونك أو أنشر طلب شراء
CAS 115314-17-5
(S)-(+)-Glycidyl-4-nitrobenzoate
Chiral building block for synthesis
(R)-(-)-Glycidyl-4-nitrobenzenesulfonate
chiral intermediate for active pharmaceutical ingredients
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
pharmaceutical intermediate
(2-BOC-AMINOPHENYL)BORONIC ACID
Pharmaceutical intermediate for boronic acid synthesis
1-(tert-Butoxycarbonyl)-3-(cyanomethylene)azetidine
pharmaceutical research intermediate
2H,4H,5H,6H,7H,7aH-thieno[3,2-c]pyridin-2-one hydrochloride
pharmaceutical intermediate
Glycidyl 3-nitrobenzenesulfonate
Pharmaceutical intermediate
(2R)-(-)-Glycidyl tosylate
Pharmaceutical intermediate for chiral synthesis
[(2R)-oxiran-2-yl]methyl 3-nitrobenzenesulfonate
AIHIHVZYAAMDPM-MRVPVSSYSA-N
C1[C@@H](O1)COS(=O)(=O)C2=CC=CC(=C2)[N+](=O)[O-]